Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein

Clipstone, 1992, Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation, Nature, 357, 695, 10.1038/357695a0 Clynes, 2000, Inhibitory Fc receptors modulate in vivo cytoxicity against tumour targets, Nature Med., 6, 443, 10.1038/74704 Folkman, 1989, Induction of angiogenesis during the transition from hyperplasia to neoplasia, Nature, 339, 58, 10.1038/339058a0 Garin-Chesa, 1989, Immunohistochemical analysis of human neuronectin expression in normal, reactive, and neoplastic tissues, J. Histochem. Cytochem., 37, 1767, 10.1177/37.12.2685107 Garin-Chesa, 1990, Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers, Proc. Natl. Acad. Sci. USA, 87, 7235, 10.1073/pnas.87.18.7235 Grosse-Hovest, 1999, Tumour-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: the role of targeted T-cell co-stimulation via CD28, Int. J. Cancer, 80, 138, 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J Himmler, 1990, Molecular cloning and expression of human and rat tumour necrosis factor receptor chain (p60) and its soluble derivative, tumour necrosis factor-binding protein, DNA Cell Biol., 9, 705, 10.1089/dna.1990.9.705 Holliger, 1996, Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody, Prot. Eng., 9, 299, 10.1093/protein/9.3.299 Jacobs, 1997, Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation, Cancer Immunol. Immunother., 44, 257, 10.1007/s002620050381 Karpovsky, 1984, Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies, J. Exp. Med., 160, 1686, 10.1084/jem.160.6.1686 Krebs, 1998, Specific targeting of cytokine-secreting cells: a bispecific diabody recognizing human interleukin-6 and CD3 induces T cell-mediated killing, J. Interferon Cytokine Res., 16, 569 Lanzavecchia, 1987, The use of hybrid hybridomas to target human cytotoxic T lymphocytes, Eur. J. Immunol., 17, 105, 10.1002/eji.1830170118 Mack, 1995, A small bispecific antibody construct expressed as a functional single-chain molecule with high tumour cell cytotoxicity, Proc. Natl. Acad. Sci. USA, 92, 7021, 10.1073/pnas.92.15.7021 Mack, 1997, Biological properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3, J. Immunol., 158, 3965, 10.4049/jimmunol.158.8.3965 Milstein, 1983, Hybrid hybridomas and their use in immunohistochemistry, Nature, 305, 537, 10.1038/305537a0 Park, 1999, Fibroblast activation protein, a dual specificity serine protease expressed in human tumour stromal fibroblasts, J. Biol. Chem., 274, 36505, 10.1074/jbc.274.51.36505 Peng, 1999, A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumour activity, Immunology, 163, 250 Renner, 1994, Cure of xenografted human tumours by bispecific monoclonal antibodies and human T cells, Science, 264, 833, 10.1126/science.8171337 Rettig, 1988, Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells, Proc. Natl. Acad. Sci. USA, 85, 3110, 10.1073/pnas.85.9.3110 Rettig, 1993, Regulation and hereromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin, Cancer Res., 53, 3327 Scanlan, 1994, Molecular cloning of fibroblast activation protein alpha, a member of the protease family selectively expressed in stromal fibroblasts of epithelial cancers, Proc. Natl. Acad. Sci. USA, 91, 5657, 10.1073/pnas.91.12.5657 Scherf, 1996, Cytotoxic and antitumoral activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells, Clin. Cancer Res., 2, 1523 Sogaard, 1996, Antibody-targeted superantigens in cancer immunotherapy, Immunotechnology, 2, 151, 10.1016/S1380-2933(96)00047-4 Titus, 1987, Human T-cells targeted with anti-T3 cross-linked to antitumour antibody prevent tumour growth in nude mice, J. Immunol., 147, 4018, 10.4049/jimmunol.138.11.4018 Traunecker, 1991, Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on Hläv infected cells, EMBO J., 10, 3655, 10.1002/j.1460-2075.1991.tb04932.x Weiner, 1991, Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma, J. Immunol., 147, 4035, 10.4049/jimmunol.147.11.4035 Welt, 1994, Antibody targeting in metastatic colon cancer: a phase I study of monoclonal F19 against a cell-surface protein of reactive tumour stromal fibroblasts, J. Clin. Oncol., 12, 1193, 10.1200/JCO.1994.12.6.1193 Xiang, 1997, Elimination of established murine colon carcinoma metastases by antibody–interleukin 2 fusion protein therapy, Cancer Res., 57, 4948